Bausch Health Q2 2023 Earnings Report
Key Takeaways
Bausch Health reported a strong second quarter with revenue of $2.17 billion, up 10% reported and 11% organic. GAAP net income attributable to Bausch Health Companies Inc. was $26 million, and adjusted EBITDA was $727 million, up 4%. The company raised its full-year revenue outlook and reaffirmed its adjusted EBITDA guidance.
Favorable Motion Ruling in Xifaxan® Litigation Reinforces Continuing Salix Growth Strategy
Balance Sheet Initiatives Further Enhance Liquidity Profile
Continued Evaluation of Optimal Implementation of Potential Bausch + Lomb Distribution
Revenue of $2.17 billion, Up 10% Reported and 11% Organic
Bausch Health
Bausch Health
Bausch Health Revenue by Segment
Forward Guidance
The Company increased its full year revenue guidance and reaffirmed its Adjusted EBITDA1 guidance for Total Bausch Health
Revenue & Expenses
Visualization of income flow from segment revenue to net income